Paper352245
Interactions of liposomes with mammalian cells.
Pagano RE and 1 other. Annu Rev Biophys Bioeng, 1978. Cited by 380 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Interactions of liposomes with mammalian cells. Papers, record 352245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/352245
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Physiological Phenomena | Major topic |
| Liposomes | Major topic |
| Adsorption | |
| Cell Fusion | |
| Cell Membrane Permeability | |
| Chemical Phenomena | |
| Chemistry | |
| Cholesterol | |
| Endocytosis | |
| Kinetics | |
| Macromolecular Substances | |
| Membrane Lipids | |
| Pharmaceutical Vehicles | |
| Phospholipids |
Source PubMed
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 380 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37189638 | Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189638 | PubMed |
| 36936540 | Nanoparticle surface coatings produce distinct antibacterial effects that are consistent across diverse bacterial species. | Front Toxicol | 2023 | https://conductscience.org/library/papers/36936540 | PubMed |
| 36559301 | Trends in Drug Delivery Systems for Natural Bioactive Molecules to Treat Health Disorders: The Importance of Nano-Liposomes. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36559301 | PubMed |
| 32426057 | Targeting Dysfunctional Vascular Endothelial Cells Using Immunoliposomes Under Flow Conditions. | Cell Mol Bioeng | 2020 | https://conductscience.org/library/papers/32426057 | PubMed |
| 31872342 | Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases. | Drug Deliv Transl Res | 2020 | https://conductscience.org/library/papers/31872342 | PubMed |
| 31324829 | Study on intracellular delivery of liposome encapsulated quantum dots using advanced fluorescence microscopy. | Sci Rep | 2019 | https://conductscience.org/library/papers/31324829 | PubMed |
| 28831255 | Stratum corneum lipid liposome-encapsulated panomycocin: preparation, characterization, and the determination of antimycotic efficacy against Candida spp. isolated from patients with vulvovaginitis in an in vitro human vaginal epithelium tissue model. | Int J Nanomedicine | 2017 | https://conductscience.org/library/papers/28831255 | PubMed |
| 27620062 | Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell line. | In Vitro Cell Dev Biol Anim | 2017 | https://conductscience.org/library/papers/27620062 | PubMed |
| 27436314 | Quantitative Intracellular Localization of Cationic Lipid-Nucleic Acid Nanoparticles with Fluorescence Microscopy. | Methods Mol Biol | 2016 | https://conductscience.org/library/papers/27436314 | PubMed |
| 26435455 | Targeted endothelial nanomedicine for common acute pathological conditions. | J Control Release | 2015 | https://conductscience.org/library/papers/26435455 | PubMed |
| 25547490 | The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/25547490 | PubMed |
| 24787360 | Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. | ACS Nano | 2014 | https://conductscience.org/library/papers/24787360 | PubMed |
| 24748970 | Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review). | Biomed Rep | 2014 | https://conductscience.org/library/papers/24748970 | PubMed |
| 24318098 | Liposome-mediated delivery of tobacco mosaic virus RNA into petunia protoplast : Improved conditions for liposome-protoplast incubations. | Plant Mol Biol | 1983 | https://conductscience.org/library/papers/24318098 | PubMed |
| 24190605 | Antifibrotic effect of a proline analogue delivered in liposomes to cells in culture. | Amino Acids | 1993 | https://conductscience.org/library/papers/24190605 | PubMed |
| 24183697 | The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus. | Biomaterials | 2014 | https://conductscience.org/library/papers/24183697 | PubMed |
| 24101211 | Microspectroscopic Study of Liposome-to-cell Interaction Revealed by Förster Resonance Energy Transfer. | J Fluoresc | 2014 | https://conductscience.org/library/papers/24101211 | PubMed |
| 23071918 | Study of ocular drug delivery system using drug-loaded liposomes. | Int J Pharm Investig | 2011 | https://conductscience.org/library/papers/23071918 | PubMed |
| 22069714 | The use of convection-enhanced delivery with liposomal toxins in neurooncology. | Toxins (Basel) | 2011 | https://conductscience.org/library/papers/22069714 | PubMed |
| 21876690 | Liposomal Antioxidants for Protection against Oxidant-Induced Damage. | J Toxicol | 2011 | https://conductscience.org/library/papers/21876690 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/352245
GET https://conductscience.org/api/papers/v1/352245/cited_by?page=2